Top compounds associated with response to LINC01420

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	ML210	CTRPv2	pan-cancer	AAC	0.017	0.6
mRNA	Bortezomib	CTRPv2	pan-cancer	AAC	-0.017	0.6
mRNA	piperlongumine	CTRPv2	pan-cancer	AAC	-0.016	0.6
mRNA	vorinostat:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.017	0.6
mRNA	necrosulfonamide	CTRPv2	pan-cancer	AAC	-0.019	0.6
mRNA	BRD-K27188169:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.026	0.6
mRNA	LY-2157299	CTRPv2	pan-cancer	AAC	-0.036	0.6
mRNA	PRIMA-1-Met	CTRPv2	pan-cancer	AAC	-0.025	0.6
mRNA	BRD-K90370028	CTRPv2	pan-cancer	AAC	-0.026	0.6
mRNA	BRD-K03911514	CTRPv2	pan-cancer	AAC	0.024	0.6

Download CSV